Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Sees Significant Growth in Short Interest

Carl Zeiss Meditec AG (OTCMKTS:CZMWY) was the recipient of a significant increase in short interest during the month of January. As of January 30th, there was short interest totaling 6,992 shares, an increase of 448.0% from the January 15th total of 1,276 shares. Based on an average daily trading volume, of 22,566 shares, the days-to-cover ratio is currently 0.3 days. Based on an average daily trading volume, of 22,566 shares, the days-to-cover ratio is currently 0.3 days.

Carl Zeiss Meditec Trading Down 3.3%

OTCMKTS CZMWY opened at $32.38 on Thursday. The business’s 50-day moving average price is $43.13 and its two-hundred day moving average price is $48.49. Carl Zeiss Meditec has a 12 month low of $32.02 and a 12 month high of $76.28.

Analysts Set New Price Targets

CZMWY has been the topic of several recent research reports. Sanford C. Bernstein downgraded Carl Zeiss Meditec to a “market perform” rating in a report on Monday, January 26th. The Goldman Sachs Group cut Carl Zeiss Meditec from a “buy” rating to a “neutral” rating in a report on Tuesday, January 20th. One research analyst has rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold”.

About Carl Zeiss Meditec

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.